L'Oreal says weight loss drugs are impacting beauty and skincare sales
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us".
BBC News|Thu, 22 October 2026 at 22:27
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us".
This summary was compiled from a public newswire feed. The original reporting is by BBC News and remains their copyright — read it at the source.